184 related articles for article (PubMed ID: 24704825)
21. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.
Lin DC; Yin T; Koren-Michowitz M; Ding LW; Gueller S; Gery S; Tabayashi T; Bergholz U; Kazi JU; Rönnstrand L; Stocking C; Koeffler HP
Blood; 2012 Oct; 120(16):3310-7. PubMed ID: 22942183
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Lnk in mouse induced pluripotent stem cells promotes hematopoietic cell generation.
Tashiro K; Omori M; Kawabata K; Hirata N; Yamaguchi T; Sakurai F; Takaki S; Mizuguchi H
Stem Cells Dev; 2012 Dec; 21(18):3381-90. PubMed ID: 22738147
[TBL] [Abstract][Full Text] [Related]
23. Eicosapentaenoic acid inhibits TNF-alpha-induced Lnk expression in human umbilical vein endothelial cells: involvement of the PI3K/Akt pathway.
Wan M; Li Y; Xue H; Li Q; Li J
J Nutr Biochem; 2007 Jan; 18(1):17-22. PubMed ID: 16784840
[TBL] [Abstract][Full Text] [Related]
24. LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway.
Tan M; Cheng Y; Zhong X; Yang D; Jiang S; Ye Y; Ding M; Guan G; Yang D; Zhao X
Aging (Albany NY); 2021 Jan; 13(3):4617-4633. PubMed ID: 33495419
[TBL] [Abstract][Full Text] [Related]
25. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
Koren-Michowitz M; Gery S; Tabayashi T; Lin D; Alvarez R; Nagler A; Koeffler HP
Br J Haematol; 2013 Jun; 161(6):811-20. PubMed ID: 23590807
[TBL] [Abstract][Full Text] [Related]
26. The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):415-29. PubMed ID: 22990499
[TBL] [Abstract][Full Text] [Related]
27. Linking inflammation and hypertension via LNK/SH2B3.
Dale BL; Madhur MS
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
[TBL] [Abstract][Full Text] [Related]
28. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
Gery S; Cao Q; Gueller S; Xing H; Tefferi A; Koeffler HP
J Leukoc Biol; 2009 Jun; 85(6):957-65. PubMed ID: 19293402
[TBL] [Abstract][Full Text] [Related]
29. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.
Gueller S; Goodridge HS; Niebuhr B; Xing H; Koren-Michowitz M; Serve H; Underhill DM; Brandts CH; Koeffler HP
J Leukoc Biol; 2010 Oct; 88(4):699-706. PubMed ID: 20571037
[TBL] [Abstract][Full Text] [Related]
30. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
Baran-Marszak F; Magdoud H; Desterke C; Alvarado A; Roger C; Harel S; Mazoyer E; Cassinat B; Chevret S; Tonetti C; Giraudier S; Fenaux P; Cymbalista F; Varin-Blank N; Le Bousse-Kerdilès MC; Kiladjian JJ; Velazquez L
Blood; 2010 Dec; 116(26):5961-71. PubMed ID: 20870899
[TBL] [Abstract][Full Text] [Related]
31. Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.
Gery S; Gueller S; Chumakova K; Kawamata N; Liu L; Koeffler HP
Blood; 2007 Nov; 110(9):3360-4. PubMed ID: 17693582
[TBL] [Abstract][Full Text] [Related]
32. The function of SH2B3 (LNK) in the kidney.
Blass G; Mattson DL; Staruschenko A
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F682-F685. PubMed ID: 27440780
[TBL] [Abstract][Full Text] [Related]
33. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein.
Takaki S; Tezuka Y; Sauer K; Kubo C; Kwon SM; Armstead E; Nakao K; Katsuki M; Perlmutter RM; Takatsu K
J Immunol; 2003 Jan; 170(2):703-10. PubMed ID: 12517931
[TBL] [Abstract][Full Text] [Related]
34. Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly.
Kubo-Akashi C; Iseki M; Kwon SM; Takizawa H; Takatsu K; Takaki S
Biochem Biophys Res Commun; 2004 Mar; 315(2):356-62. PubMed ID: 14766215
[TBL] [Abstract][Full Text] [Related]
35. Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk.
Takizawa H; Kubo-Akashi C; Nobuhisa I; Kwon SM; Iseki M; Taga T; Takatsu K; Takaki S
Blood; 2006 Apr; 107(7):2968-75. PubMed ID: 16332975
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Lnk. An adaptor protein expressed in lymphocytes.
Takaki S; Watts JD; Forbush KA; Nguyen NT; Hayashi J; Alberola-Ila J; Aebersold R; Perlmutter RM
J Biol Chem; 1997 Jun; 272(23):14562-70. PubMed ID: 9169414
[TBL] [Abstract][Full Text] [Related]
37. Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling.
Gueller S; Hehn S; Nowak V; Gery S; Serve H; Brandts CH; Koeffler HP
Exp Hematol; 2011 May; 39(5):591-600. PubMed ID: 21310211
[TBL] [Abstract][Full Text] [Related]
38. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis.
Neelakantan D; Dogra S; Devapatla B; Jaiprasart P; Mukashyaka MC; Janknecht R; Dwivedi SKD; Bhattacharya R; Husain S; Ding K; Woo S
Mol Cancer Res; 2019 Jun; 17(6):1378-1390. PubMed ID: 30858172
[TBL] [Abstract][Full Text] [Related]
40. Adaptor protein Lnk associates with Tyr(568) in c-Kit.
Gueller S; Gery S; Nowak V; Liu L; Serve H; Koeffler HP
Biochem J; 2008 Oct; 415(2):241-5. PubMed ID: 18588518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
